0910-AF26 200904 Unified Agenda of Federal Regulatory and Deregulatory Actions 0910 Food and Drug Administration FDA 0900 Department of Health and Human Services HHS Blood Initiative--Revisions to Labeling Requirements for Blood and Blood Components, Including Source Plasma; and Technical Amendment Other Significant Previously Published in The Unified Agenda Final Rule Stage No No 21 CFR 606 21 CFR 610 21 CFR 640 21 USC 321 21 USC 331 21 USC 351 to 353 21 USC 355 21 USC 360 21 USC 360d 21 USC 360h to 360j 21 USC 371 21 USC 374 21 USC 381 42 USC 216 42 USC 262 and 263 42 USC 263a 42 USC 264 No NPRM 07/30/2003 68 FR 44678 NPRM Comment Period End 10/28/2003 Final Action 03/00/2010 No No None No No No 0910-AB26 Split from Laura Rich 0910 Food and Drug Administration FDA 877 287-1373 ctpregulations@fda.hhs.gov Center for Tobacco Products, 10903 New Hampshire Avenue, Building 71, Room G335, Silver Spring MD 20993